Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Avalo Therapeutics Inc (NASDAQ: AVTX)

 
AVTX Technical Analysis
4
As on 9th Jun 2023 AVTX STOCK Price closed @ 4.02 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.47 & Strong Buy for SHORT-TERM with Stoploss of 1.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AVTXSTOCK Price

Open 4.08 Change Price %
High 4.38 1 Day -0.13 -3.13
Low 4.01 1 Week 1.15 40.07
Close 4.02 1 Month 1.20 42.55
Volume 27100 1 Year 2.17 117.30
52 Week High 6.90 | 52 Week Low 0.25
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
AVTX
Daily Charts		 AVTX
Intraday Charts		 Whats New @
Bazaartrend		 AVTX
Free Analysis
 
AVTX Important Levels Intraday
RESISTANCE4.73
RESISTANCE4.50
RESISTANCE4.36
RESISTANCE4.22
SUPPORT3.82
SUPPORT3.68
SUPPORT3.54
SUPPORT3.31
 
AVTX Forecast April 2024
Share
4th UP Forecast4.89
3rd UP Forecast4.61
2nd UP Forecast4.44
1st UP Forecast4.27
1st DOWN Forecast3.77
2nd DOWN Forecast3.6
3rd DOWN Forecast3.43
4th DOWN Forecast3.15
 
AVTX Weekly Forecast
4th UP Forecast4.56
3rd UP Forecast4.39
2nd UP Forecast4.28
1st UP Forecast4.17
1st DOWN Forecast3.87
2nd DOWN Forecast3.76
3rd DOWN Forecast3.65
4th DOWN Forecast3.48
 
AVTX Forecast2024
4th UP Forecast17.35
3rd UP Forecast13.08
2nd UP Forecast10.43
1st UP Forecast7.79
1st DOWN Forecast0.25
2nd DOWN Forecast-2.39
3rd DOWN Forecast-5.04
4th DOWN Forecast-9.31
 
 
AVTX Other Details
Segment EQ
Market Capital 258892992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AVTX Address
AVTX
 
AVTX Latest News
 
Your Comments and Response on Avalo Therapeutics Inc
 
AVTX Business Profile
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. Its product pipeline includes AVTX-002, an Anti-LIGHT mAb targeting immune-inflammatory diseases, including acute respiratory distress syndrome and moderate-to-severe inflammatory bowel disease; and AVTX-007, an Anti-IL-18 mAb targeting immuno-oncology and immune-inflammatory diseases, including multiple myeloma and Still's disease. The company also engages in developing AVTX-006, a dual mTORc1/c2 inhibitor targeting lymphatic malformations; and AVTX 800 programs (AVTX-801, AVTX-802, and AVTX-803), which are therapeutic doses of monosaccharide therapies for congenital disorders of glycosylation. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service